Use of Investigational Products When Subjects Enter a Second Institution: Guidance for Institutional Review Boards and Clinical Investigators

Detailed guidance document from FDA and regulatory agencies.

Document Details

Document Type

Information Sheet

Issue Date

January 1, 1998

Office

Office of the Commissioner,Office of Clinical Policy and Programs,Office of Clinical Policy,Office of Good Clinical Practice

Document ID

e2034c31-e0cf-45da-af64-82293c9af76c

Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.